Hepatitis B in men who have sex with men and HIV-infected individuals: missed opportunities and future challenges

References

[1]  Szmuness W, Stevens CE, Harley EJ, Zang EA, Oleszko WR, William DC, et al Hepatitis B vaccine: demonstration of efficacy in a controlled clinical trial in a high-risk population in the United States. N Engl J Med 1980; 303 833–41.
| Hepatitis B vaccine: demonstration of efficacy in a controlled clinical trial in a high-risk population in the United States.Crossref | GoogleScholarGoogle Scholar | 6997738PubMed |

[2]  National Health and Medical Research Council (NHMRC). Recommendations on hepatitis B immunisation: Report by NHMRC Hepatitis B Working Party. Canberra: NHMRC; 1996.

[3]  Body A, Hoy JF, Cheng AC, Giles ML. Incident hepatitis B infection subsequent to the diagnosis of HIV infection in a Melbourne cohort: missed opportunities for prevention. Sex Health 2014; 11 5–10.
| Incident hepatitis B infection subsequent to the diagnosis of HIV infection in a Melbourne cohort: missed opportunities for prevention.Crossref | GoogleScholarGoogle Scholar |

[4]  Gamagedara N, Weerakoon AP, Zou H, Fehler G, Chen MY, Read TR, et al Cross-sectional study of hepatitis B immunity in MSM between 2002 and 2012. Sex Transm Infect 2013;
| Cross-sectional study of hepatitis B immunity in MSM between 2002 and 2012.Crossref | GoogleScholarGoogle Scholar | 23920399PubMed |

[5]  Wheeler E, Cowie B. Be aware – hepatitis B as an STI. Aust Nurs J 2011; 19 41–2.
| 22329110PubMed |

[6]  Australian Government Department of Health and Ageing (DoHA). National notifiable diseases surveillance system. Canberra: DoHA; 2013. Available online at: http://www9.health.gov.au/cda/Source/CDA-index.cfm [verified November 2013].

[7]  The Kirby Institute. National blood-borne virus and sexually transmissible infections surveillance and monitoring Report, 2012. Sydney: The Kirby Institute, the University of New South Wales; 2013.

[8]  Maclachlan J, Allard N, Towell V, Cowie B. Aust NZ J Public Health 2013; 37 416–22.
| Crossref | GoogleScholarGoogle Scholar |

[9]  Australian Government Department of Health and Ageing (DoHA). National hepatitis B strategy 2010–2013. Canberra: DoHA; 2010.

[10]  The Kirby Institute. HIV, viral hepatitis and sexually transmissible infections in Australia: annual surveillance report 2012. Sydney: The Kirby Institute, The University of New South Wales; 2012.

[11]  Clifford GM, Rickenbach M, Polesel J, Dal Maso L, Steffen I, Ledergerber B, et al Influence of HIV-related immunodeficiency on the risk of hepatocellular carcinoma. AIDS 2008; 22 2135–41.
| Influence of HIV-related immunodeficiency on the risk of hepatocellular carcinoma.Crossref | GoogleScholarGoogle Scholar | 18832877PubMed |

[12]  McMahon BJ, Alward WL, Hall DB, Heyward WL, Bender TR, Francis DP, et al Acute hepatitis B virus infection: relation of age to the clinical expression of disease and subsequent development of the carrier state. J Infect Dis 1985; 151 599–603.
| Acute hepatitis B virus infection: relation of age to the clinical expression of disease and subsequent development of the carrier state.Crossref | GoogleScholarGoogle Scholar | 3973412PubMed |

[13]  Australasian Society for HIV Medicine. National Hepatitis B Testing Policy. Sydney: Department of Health and Aging; 2012.

[14]  National Health and Medical Research Council (NHMRC). The Australian immunisation handbook. 10th edn. Canberra: NHMRC, Department of Health and Ageing; 2013.

[15]  Mast EE, Weinbaum CM, Fiore AE, Alter MJ, Bell BP, Finelli L, et al A comprehensive immunization strategy to eliminate transmission of hepatitis B virus infection in the United States: recommendations of the Advisory Committee on Immunization Practices (ACIP) part II: immunization of adults. MMWR Recomm Rep 2006; 55 1–33.
| 17159833PubMed |

[16]  Topp L, Day CA, Wand H, Deacon RM, van Beek I, Haber PS, et al A randomised controlled trial of financial incentives to increase hepatitis B vaccination completion among people who inject drugs in Australia. Prev Med 2013;
| A randomised controlled trial of financial incentives to increase hepatitis B vaccination completion among people who inject drugs in Australia.Crossref | GoogleScholarGoogle Scholar | 23639625PubMed |

[17]  Rock C, de Barra E, Sadlier C, Kelly S, Dowling C, McNally C, et al Impact of a new vaccine clinic on hepatitis B vaccine completion and immunological response rates in an HIV-positive cohort. J Infect Public Health 2013; 6 173–8.
| Impact of a new vaccine clinic on hepatitis B vaccine completion and immunological response rates in an HIV-positive cohort.Crossref | GoogleScholarGoogle Scholar | 23668461PubMed |

[18]  Macdonald V, Dore GJ, Amin J, van Beek I. Predictors of completion of a hepatitis B vaccination schedule in attendees at a primary health care centre. Sex Health 2007; 4 27–30.
| Predictors of completion of a hepatitis B vaccination schedule in attendees at a primary health care centre.Crossref | GoogleScholarGoogle Scholar | 17382034PubMed |

[19]  Potsch DV, Camacho LA, Tuboi S, Villar LM, Miguel JC, Ginuino C, et al Vaccination against hepatitis B with 4-double doses increases response rates and antibodies titers in HIV-infected adults. Vaccine 2012; 30 5973–7.
| Vaccination against hepatitis B with 4-double doses increases response rates and antibodies titers in HIV-infected adults.Crossref | GoogleScholarGoogle Scholar | 22828589PubMed |

[20]  Launay O, van der Vliet D, Rosenberg AR, Michel ML, Piroth L, Rey D, et al Safety and immunogenicity of 4 intramuscular double doses and 4 intradermal low doses vs standard hepatitis B vaccine regimen in adults with HIV-1: a randomized controlled trial. JAMA 2011; 305 1432–40.
| Safety and immunogenicity of 4 intramuscular double doses and 4 intradermal low doses vs standard hepatitis B vaccine regimen in adults with HIV-1: a randomized controlled trial.Crossref | GoogleScholarGoogle Scholar | 21486976PubMed |

[21]  Lopes VB, Hassing RJ, de Vries-Sluijs TE, El Barzouhi A, Hansen BE, Schutten M, et al Long-term response rates of successful hepatitis B vaccination in HIV-infected patients. Vaccine 2013; 31 1040–4.
| Long-term response rates of successful hepatitis B vaccination in HIV-infected patients.Crossref | GoogleScholarGoogle Scholar | 23273969PubMed |

[22]  McMahon BJ, Dentinger CM, Bruden D, Zanis C, Peters H, Hurlburt D, et al Antibody levels and protection after hepatitis B vaccine: results of a 22-year follow-up study and response to a booster dose. J Infect Dis 2009; 200 1390–6.
| Antibody levels and protection after hepatitis B vaccine: results of a 22-year follow-up study and response to a booster dose.Crossref | GoogleScholarGoogle Scholar | 19785526PubMed |

[23]  Wu Q, Zhuang GH, Wang XL, Wang LR, Li N, Zhang M. Antibody levels and immune memory 23 years after primary plasma-derived hepatitis B vaccination: results of a randomized placebo-controlled trial cohort from China where endemicity is high. Vaccine 2011; 29 2302–7.
| Antibody levels and immune memory 23 years after primary plasma-derived hepatitis B vaccination: results of a randomized placebo-controlled trial cohort from China where endemicity is high.Crossref | GoogleScholarGoogle Scholar | 21277403PubMed |

[24]  Banatvala J, Van Damme P, Van Hattum J. Are booster immunisations needed for lifelong hepatitis B immunity? European Consensus Group on Hepatitis B Immunity. Lancet 2000; 355 561–5.
| Are booster immunisations needed for lifelong hepatitis B immunity? European Consensus Group on Hepatitis B Immunity.Crossref | GoogleScholarGoogle Scholar |

[25]  Wu TW, Lin HH, Wang LY. Chronic hepatitis B infection in adolescents who received primary infantile vaccination. Hepatology 2013; 57 37–45.
| Chronic hepatitis B infection in adolescents who received primary infantile vaccination.Crossref | GoogleScholarGoogle Scholar | 22858989PubMed |

[26]  Gidding HF, Warlow M, MacIntyre CR, Backhouse J, Gilbert GL, Quinn HE, et al The impact of a new universal infant and school-based adolescent hepatitis B vaccination program in Australia. Vaccine 2007; 25 8637–41.
| The impact of a new universal infant and school-based adolescent hepatitis B vaccination program in Australia.Crossref | GoogleScholarGoogle Scholar | 18054127PubMed |

[27]  Cowie B, Karapanagiotidis T, Enriquez A, Kelly H. Markers of hepatitis B virus infection and immunity in Victoria, Australia, 1995 to 2005. Aust N Z J Public Health 2010; 34 72–8.
| Markers of hepatitis B virus infection and immunity in Victoria, Australia, 1995 to 2005.Crossref | GoogleScholarGoogle Scholar | 20920109PubMed |

[28]  Gatanaga H, Hayashida T, Tanuma J, Oka S. Prophylactic effect of antiretroviral therapy on hepatitis B virus infection. Clin Infect Dis 2013; 56 1812–9.
| 23487374PubMed |

[29]  ACT Government Health Directorate (ACTGHD). ACT health information. Hepatitis B fact sheet. Canberra: ACTGHD; 2013. Available online at: http://health.act.gov.au/publications-reports/fact-sheets/hepatitis-b [verified October 2013].

[30]  NSW Department of Health. Additional vaccines provided free in NSW. Sydney: NSW Health; 2013. Available online at: http://www.health.nsw.gov.au/immunisation/Pages/gp_catchup.aspx [verified September 2013].

[31]  Northern Territory Government. Adult and special groups vaccination schedule. Darwin: Northern Territory Government; 2013. Available online at: http://www.health.nt.gov.au/library/scripts/objectifyMedia.aspx?file=pdf/63/90.pdf&siteID=1&str_title=Adult%20and%20Special%20Groups%20Vaccination%20Schedule.pdf [verified October 2013].

[32]  Queensland Health. Hepatitis B and immunisation 2013. Brisbane: Queensland Health; 2013. Available online at: http://access.health.qld.gov.au/hid/InfectionsandParasites/ImmunisationandVaccination/hepatitisBAndImmunisation_ap.asp [verified October 2013].

[33]  SA Health. High risk hepatitis B immunisation program. Adelaide: Government of South Australia; 2013. Available online at: http://www.sahealth.sa.gov.au/wps/wcm/connect/public+content/sa+health+internet/health+topics/health+conditions+prevention+and+treatment/ immunisation/immunisation+programs/high+risk+hepatitis+b+immunisation+program/high+risk+hepatitis+b+immunisation+program [verified October 2013].

[34]  Department of Health and Human Services Tasmania (DHHST). Hepatitis B virus. Hobart: DHHST; 2013. Available online at: http://www.dhhs.tas.gov.au/peh/infectious_diseases/hep_b [verified October 2013].

[35]  Western Australian Heath Department (WAHD). Guidelines for the provision of hepatitis A and B vaccine to adults in Western Australia at risk of acquiring these infections by sexual transmission and injecting drug use. Perth: WAHD; 2012. Available online at: http://www.health.wa.gov.au/circularsnew/attachments/700.pdf [verified November 2013].

[36]  Department of Health Victoria. Free vaccine Victoria – criteria for eligibility. Melbourne: Department of Health, Victoria; 2013. Available online at: http://www.health.vic.gov.au/immunisation/free-vaccine.htm [verified November 2013].